Anderson Cynthia Lynn has filed 5 insider transactions across 1 company since June 2024.
Most recent transaction: a grant/award of 6617 shares of Vistagen Therapeutics, Inc. ($VTGN) on June 30, 2025.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| June 30, 2025 | Vistagen Therapeutics, Inc. | $VTGN | Anderson Cynthia Lynn | CHIEF FINANCIAL OFFICER | A | Common Stock | 6617 | $1.70 | 12,801.0000 | 29,157,733 | 107.00% | 0.02% |
| June 23, 2025 | Vistagen Therapeutics, Inc. | $VTGN | Anderson Cynthia Lynn | CHIEF FINANCIAL OFFICER | A | Stock Option (Right to Buy) | 100000 | $0.00 | 100,000.0000 | 29,157,733 | 9999.99% | 0.34% |
| Dec. 31, 2024 | Vistagen Therapeutics, Inc. | $VTGN | Anderson Cynthia Lynn | CHIEF FINANCIAL OFFICER | A | Common Stock | 2592 | $2.51 | 6,184.0000 | 30,632,347 | 72.16% | 0.01% |
| June 28, 2024 | Vistagen Therapeutics, Inc. | $VTGN | Anderson Cynthia Lynn | CHIEF FINANCIAL OFFICER | A | Common Stock | 3592 | $2.96 | 3,592.0000 | 19,354,500 | 9999.99% | 0.02% |
| June 24, 2024 | Vistagen Therapeutics, Inc. | $VTGN | Anderson Cynthia Lynn | CHIEF FINANCIAL OFFICER | A | Stock Option (Right to Buy) | 150000 | $0.00 | 150,000.0000 | 19,354,500 | 9999.99% | 0.78% |